Status:
RECRUITING
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Opioid Misuse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Ind...
Detailed Description
Given the health disparities in AI/AN populations and lack of access to quality care for comorbid chronic pain and opioid misuse/OUD, the proposed study seeks to build upon the strong relationships be...
Eligibility Criteria
Inclusion
- Willing and able to provide informed consent
- have English comprehension and proficiency
- receiving services at one of our participating study sites
- report current chronic pain and/or opioid misuse/opioid use disorder
- self-identify as American Indian/Alaska Native
Exclusion
- if they have a psychiatric, cognitive, or medical condition that interferes with the consenting process
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT06565416
Start Date
June 1 2023
End Date
July 1 2028
Last Update
November 12 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic Site A (blinded pending tribal approval)
Arcata, California, United States, 95521
2
Clinic Site C (blinded pending tribal approval)
Minneapolis, Minnesota, United States, 55404
3
Clinic Site B (blinded pending tribal approval)
Toppenish, Washington, United States, 98948